ATXA Therapeutics Founder & CEO Receives 2024 NovaUCD Innovation Award
Professor Therese Kinsella, founder and CEO of ATXA Therapeutics, has been named the recipient of the 2024 NovaUCD Innovation Award....
ATXA Therapeutics Founder & CEO Receives 2024 NovaUCD Innovation Award
ATXA Therapeutics Publishes Results of Phase 1 First-in-Human Study Evaluating the Safety & Tolerability of NTP42 in Healthy Volunteers
ATXA Therapeutics to Participate in Bio€quity Europe 2023
ATXA to Present at ATS International Conference 2023
NTP42 Demonstrates Key Cardioprotective Benefits in Newly-published Preclinical Findings
ATXA Therapeutics receives Funding through the European Innovation Council Accelerator Programme
ATXA Presentation at ERS International Congress 2022
European Commission publish article on ATXA's PAH-HOPE project
ATXA Presentation at ESC Congress 2021